|
GB1570494A
(en)
*
|
1975-11-28 |
1980-07-02 |
Ici Ltd |
Thienopyrimidine derivatives and their use as pesticides
|
|
US5280026A
(en)
*
|
1989-05-30 |
1994-01-18 |
Smithkline Beecham Intercredit B.V. |
Thienopyrimidines
|
|
GB8912335D0
(en)
*
|
1989-05-30 |
1989-07-12 |
Smithkline Beckman Intercredit |
Compounds
|
|
US5098902A
(en)
*
|
1991-03-18 |
1992-03-24 |
Warner-Lambert Company |
Method of treating neurodegenerative diseases
|
|
US6187777B1
(en)
|
1998-02-06 |
2001-02-13 |
Amgen Inc. |
Compounds and methods which modulate feeding behavior and related diseases
|
|
US6608053B2
(en)
*
|
2000-04-27 |
2003-08-19 |
Yamanouchi Pharmaceutical Co., Ltd. |
Fused heteroaryl derivatives
|
|
GB0423653D0
(en)
|
2004-10-25 |
2004-11-24 |
Piramed Ltd |
Pharmaceutical compounds
|
|
SI1874781T1
(sl)
*
|
2006-04-19 |
2009-12-31 |
Boehringer Ingelheim Int |
Dihidrotienopirimidini za zdravljenje vnetnih obolenj
|
|
EP1847543A1
(de)
|
2006-04-19 |
2007-10-24 |
Boehringer Ingelheim Pharma GmbH & Co. KG |
Dihydrothienopyrimidine zur Behandlung von entzündlichen Erkrankungen
|
|
AU2007243457B2
(en)
*
|
2006-04-26 |
2012-02-23 |
F. Hoffmann-La Roche Ag |
Pharmaceutical compounds
|
|
DK2024372T3
(da)
|
2006-04-26 |
2010-09-20 |
Hoffmann La Roche |
Thieno[3,2-d]pyrimidin-derivat, der er egnet som P13K inhibitor
|
|
CL2007001166A1
(es)
*
|
2006-04-26 |
2008-01-25 |
Piramed Ltd |
Compuestos derivados de pirimidina condensada, inhibidores de pi3-quinasa; procesos para preparar los compuestos; composicion farmaceutica que los comprende; uso de los compuestos en la preparacion de medicamentos; proceso para preparar la composicion farmaceutica; y kit que incluye a la composicion farmaceutica
|
|
JP5284977B2
(ja)
*
|
2006-12-07 |
2013-09-11 |
エフ・ホフマン−ラ・ロシュ・アクチェンゲゼルシャフト |
ホスホイノシチド３−キナーゼ阻害剤化合物及び使用方法
|
|
US9487533B2
(en)
*
|
2006-12-07 |
2016-11-08 |
Genentech, Inc. |
Phosphoinositide 3-kinase inhibitor compounds and methods of use
|
|
EP2207781B1
(en)
|
2007-09-24 |
2012-11-28 |
Genentech, Inc. |
Thiazolopyrimidine p13k inhibitor compounds and methods of use
|
|
PT2610258E
(pt)
*
|
2007-10-19 |
2014-10-24 |
Boehringer Ingelheim Int |
Piperidino-di-hidrotienopirimidinas substituídas
|
|
RU2500681C2
(ru)
|
2007-10-19 |
2013-12-10 |
Берингер Ингельхайм Интернациональ Гмбх |
Замещенные гетероциклом пиперазинодигидротиенопиримидины
|
|
WO2009050236A1
(de)
|
2007-10-19 |
2009-04-23 |
Boehringer Ingelheim International Gmbh |
Neue piperazino-dihydrothienopyrimidin-derivate
|
|
ES2439705T3
(es)
|
2007-10-25 |
2014-01-24 |
Genentech, Inc. |
Proceso para la preparación de compuestos de tienopirimidina
|
|
GB0721095D0
(en)
*
|
2007-10-26 |
2007-12-05 |
Piramed Ltd |
Pharmaceutical compounds
|
|
EP2405916B1
(en)
|
2009-03-12 |
2018-02-07 |
Genentech, Inc. |
Combinations of phosphoinositide 3-kinase inhibitor compounds and chemotherapeutic agents for the treatment of hematopoietic malignancies
|
|
US8158625B2
(en)
*
|
2009-05-27 |
2012-04-17 |
Genentech, Inc. |
Bicyclic indole-pyrimidine PI3K inhibitor compounds selective for P110 delta, and methods of use
|
|
BRPI1009022A2
(pt)
*
|
2009-05-27 |
2016-03-08 |
Hoffmann La Roche |
"composto, composição farmacêutica, processo para produzir uma composição farmacêutica, uso de um composto, método para tratamento de uma doença ou transtorno e kit"
|
|
MA33974B1
(fr)
*
|
2009-10-12 |
2013-02-01 |
Hoffmann La Roche |
Combinaisons d'un inhibiteur de pi3k et d'un inhibiteur de mek
|
|
MX2012011887A
(es)
|
2010-04-16 |
2012-11-30 |
Genentech Inc |
Foxo 3a como biomarcador predictivo para la eficacia del inhibidor de la via de quinasa pi3k/akt.
|
|
WO2012088254A1
(en)
|
2010-12-22 |
2012-06-28 |
Genentech, Inc. |
Autophagy inducer and inhibitor combination therapy for the treatment of neoplasms
|
|
US9802954B2
(en)
|
2011-08-24 |
2017-10-31 |
Boehringer Ingelheim International Gmbh |
Piperidino-dihydrothienopyrimidine sulfoxides and their use for treating COPD and asthma
|
|
US20130059866A1
(en)
|
2011-08-24 |
2013-03-07 |
Boehringer Ingelheim International Gmbh |
Novel piperidino-dihydrothienopyrimidine sulfoxides and their use for treating copd and asthma
|
|
BR112015020054A2
(pt)
|
2013-02-25 |
2017-08-29 |
Genentech Inc |
Método de detectar resistência aos efeitos terapêuticos de um inibidor de akt em uma célula cancerosa
|
|
IL281811B2
(en)
*
|
2018-10-01 |
2025-03-01 |
Genzyme Corp |
Thieno[3,2-B]pyridine derivatives as UPD glycosyltransferase inhibitors and methods of use
|
|
GB202014736D0
(en)
*
|
2020-09-18 |
2020-11-04 |
Imperial College Innovations Ltd |
Novel compounds and their use in therapy
|